Contract 36C26222P0370
Oxford Gene Technology Inc · Department Of Veterans Affairs · December 28, 2021
Oxford Gene Technology Inc was awarded a federal contract by Department Of Veterans Affairs on December 28, 2021 for $29,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Los Angeles, CA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 20, 2026.
Contract details
- PIID
- 36C26222P0370
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Los Angeles, CA
- First action
- December 28, 2021
- Latest action
- March 20, 2026
Description
CYTOCELL FISH PROBES AND REAGENTS
Modification timeline
-
March 20, 2026Mod P00001$-24.6K
-
December 28, 2021Base award$53.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Ortho-Clinical Diagnostics, Inc | Department Of Veterans Affairs | April 1, 2026 | $221.9K |
| Roche Diagnostics Corporation | Department Of Veterans Affairs | April 1, 2026 | $735.4K |
| Abbott Laboratories Inc. | Department Of Veterans Affairs | April 1, 2026 | $1.56M |
| Bio Rad Laboratories Inc | Department Of Veterans Affairs | April 1, 2026 | $189.7K |
| Beckman Coulter, Inc | Department Of Veterans Affairs | March 31, 2026 | $95.6K |
| Veterans Healthcare Supply Solutions, Inc | Department Of Veterans Affairs | March 31, 2026 | $176.8K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26222P0370?
Contract 36C26222P0370 is a federal contract awarded to Oxford Gene Technology Inc by Department Of Veterans Affairs on December 28, 2021 for $29,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36C26222P0370?
Oxford Gene Technology Inc won contract 36C26222P0370 from Department Of Veterans Affairs.
How much is contract 36C26222P0370 worth?
Contract 36C26222P0370 has obligated $29,000 to date.